Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery  Elisabeth Ott,

Slides:



Advertisements
Similar presentations
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery Nancy A. Nussmeier, M.D., Andrew A. Whelton, M.D., Mark T. Brown,
Advertisements

The “occasional open heart surgeon” revisited
Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.
Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts  Robert H. Habib, PhD,
Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 
A wolf in sheep's clothing
The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.
Intraoperative bypass graft flow in intra-aortic balloon pump–supported patients: Differences in arterial and venous sequential conduits  Francesco Onorati,
Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D
LiQian Chen, MD, PhD, Arthur W
CD133+ cells: How could they have an IMPACT?
Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting?  Khalil Masabni, MD,
Juan A. Crestanello, MD, Richard C. Daly, MD 
Defining operative mortality: Impact on outcome reporting
Gender profiling in coronary artery bypass grafting
Steven R. Gundry, MD, Matthew A. Romano, MD, O
Multilevel data analysis: What? Why? How?
Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all  David Faraoni, MD,
Go on-pump or off-pump in diabetic patients?
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Gender differences in quality of distal vessels: effect on results of coronary artery bypass grafting  Lynda L Mickleborough, MD, Susan Carson, AHT, Joan.
Predictors of contemporary coronary artery bypass grafting outcomes
The lord of the rings  Antonio Miceli, MD, PhD 
Igor E. Konstantinov, MD, PhD, FRACS 
Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.
The COX-2 Specific Inhibitor, Valdecoxib, Is An Effective, Opioid-Sparing Analgesic in Patients Undergoing Total Knee Arthroplasty  Lowell W Reynolds,
Support Your Specialty
Michael Mack, MD, David Taggart, MD 
Innovation and science: The future of valve design
Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years 
A first start for lung transplantation?
Stephen R. Broderick, MD, MPHS 
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Niv Ad, MD, Lawrence M. Wei, MD 
Guidelines should bother us, not comfort us
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
The Ross procedure: Time to reevaluate the guidelines
Shengshou Hu, MD, Xin Yuan, MD, PhD 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
Treatment of deep sternal wound infections after coronary artery bypass grafting by means of injection of platelet gel: An evolving technology  Erez Kachel,
Predictive value of the National Institutes of Health Stroke Scale and the Mini-Mental State Examination for neurologic outcome after coronary artery.
Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes  Sitaram M. Emani, MD  The Journal of Thoracic.
Shunt right or left? Decision 2016
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
The harder one looks, the more one finds
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting  Castigliano M. Bhamidipati,
Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005  Howard K. Song, MD, PhD, Brian S. Diggs,
Long-term results of heart transplantation in patients older than 60 years  Philippe Demers, MD, MSc, FRCSC, Susan Moffatt, MD, PhD, FRCSC, Philip E Oyer,
Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD 
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Managing conflicts of interest
More than vital: Who bears the burden?
A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
What surgical improvements are needed to prove that anatomic repair is superior to physiologic repair in the majority of patients with corrected transposition.
Time-related mortality for women after coronary artery bypass graft surgery: a population-based study  Veena Guru, MD, Stephen E Fremes, MD, MSc, Jack.
Journal changes and initiatives
IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting?  Tomislav Kopjar, MD, PhD, Michael R. Dashwood,
Intraoperative endocardial ultrasonography: Improving safety in mitral valve surgery  Juan A. Crestanello, MD  The Journal of Thoracic and Cardiovascular.
Edward Y. Chan, MD, Michael J. Reardon, MD 
Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa.
Presentation transcript:

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery  Elisabeth Ott, MD, Nancy A. Nussmeier, MD, Peter C. Duke, MD, Robert O. Feneck, MD, R.Peter Alston, MD, Michael C. Snabes, MD, PhD, Richard C. Hubbard, MD, Ping H. Hsu, PhD, Lawrence J. Saidman, MD, Dennis T. Mangano, PhD, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 125, Issue 6, Pages 1481-1492 (June 2003) DOI: 10.1016/S0022-5223(03)00125-9

Figure 1 Peak pain intensity difference is defined as the reduction of peak pain intensity from baseline values. Higher values of peak pain intensity difference indicate less pain. ∗P < .050 for analysis of covariance with treatment and country as factors and baseline pain intnsity as covariate. The Journal of Thoracic and Cardiovascular Surgery 2003 125, 1481-1492DOI: (10.1016/S0022-5223(03)00125-9)